Novozymes A/S - NVZMF Competitors

Novozymes A/S (OTCMKTS:NVZMF) and 3SBio (OTCMKTS:TRSBF) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, valuation, risk, analyst recommendations, community ranking, dividends, earnings, profitability and institutional ownership.

Which has stronger valuation and earnings, NVZMF or TRSBF?

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Novozymes A/S	N/A	N/A	N/A	$8.02	6.21
3SBio	N/A	N/A	N/A	N/A	N/A

Does the media refer more to NVZMF or TRSBF?

In the previous week, 3SBio's average media sentiment score of 0.98 beat Novozymes A/S's score of 0.00 indicating that 3SBio is being referred to more favorably in the news media.

Company	Overall Sentiment
Novozymes A/S	Neutral
3SBio	Positive

Is NVZMF or TRSBF more profitable?

Company	Net Margins	Return on Equity	Return on Assets
Novozymes A/S	N/A	N/A	N/A
3SBio	N/A	N/A	N/A

Does the MarketBeat Community favor NVZMF or TRSBF?

Novozymes A/S received 41 more outperform votes than 3SBio when rated by MarketBeat users.

Company	Underperform	Outperform
Novozymes A/S	Outperform Votes 41 56.94%	Underperform Votes 31 43.06%
3SBio	N/A	N/A

Do analysts recommend NVZMF or TRSBF?

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Novozymes A/S	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
3SBio	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Do institutionals and insiders hold more shares of NVZMF or TRSBF?

20.4% of Novozymes A/S shares are held by institutional investors. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Novozymes A/S beats 3SBio on 2 of the 3 factors compared between the two stocks.